As the world continues to navigate the aftermath of the COVID-19 pandemic, many individuals face prolonged health issues long after their initial recovery from the virus. Known as long COVID, this condition presents a complex array of symptoms that persist for more than 12 weeks after testing positive for COVID-19. These symptoms can vary widely in severity and can fluctuate daily. Commonly, long COVID is characterized by fatigue, but researchers at the Hunter Medical Research Institute (HMRI) have identified chest symptoms, such as shortness of breath, as prevalent.
Individuals with chronic diseases, such as type 2 diabetes, are at a higher risk of developing severe COVID-19 illness and, consequently, long COVID. The enduring effects of long COVID complicate diabetes management, making it difficult to maintain blood sugar control. Symptoms like shortness of breath hinder daily functioning and limit physical activity, which is crucial for managing type 2 diabetes. Regular exercise is essential for improving blood sugar levels, heart health, and reducing the risk of diabetes-related complications.
Dr. Emily Cox, an accredited exercise physiologist and researcher in HMRI’s Active Living and Learning Research Program, is leading a study to develop a personalized, eight-week exercise program specifically for individuals with type 2 diabetes who are experiencing long COVID symptoms. This research, funded by Diabetes Australia, aims to enhance the prescription and delivery of exercise programs for this vulnerable population, mirroring the structure of the current Medicare-subsidized type 2 diabetes group exercise program.
“We want to compare the effects of a specialized long COVID symptom-guided exercise program with current diabetes care services,” says Dr. Cox. “It’s crucial that those experiencing symptoms like shortness of breath are prescribed exercise that is both safe and effective.”
The study seeks to build a robust evidence base for utilizing exercise in people with type 2 diabetes and long COVID, with the goal of integrating it into routine clinical care. By participating, individuals aged 18 and older who have type 2 diabetes and experienced COVID-19 more than 12 weeks ago, and who are facing ongoing symptoms that impact their ability to exercise, can contribute to this important research.
This initiative represents a promising step towards improving health outcomes for type 2 diabetics living with long COVID, ensuring they receive the right care to safely return to or begin exercising.
Related topics:
Periodontitis in Diabetes Patients and Its Association with Diabetes-Related Complications
Sustained Non-Diabetic Status After IGT Diagnosis Reduces Cardiovascular Risks, Study Finds
Combined Diabetes Medications Show Promise in Reducing Cardiovascular and Kidney Risks
